Jump Financial, LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Jump Financial, LLC

  • $4.56 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
SELL
$17.63 - $21.74 $73,023 - $90,047
-4,142 Reduced 7.64%
50,078 $988,000
Q4 2023

Oct 21, 2024
BUY
$14.37 - $19.07 $779,141 - $1.03 Million
54,220 New
54,220 $951,000
Q4 2023

Feb 07, 2024
BUY
$14.37 - $19.07 $779,141 - $1.03 Million
54,220 New
54,220 $951,000
Q3 2022

Nov 07, 2022
SELL
$9.76 - $13.41 $43,129 - $59,258
-4,419 Reduced 18.55%
19,400 $249,000
Q2 2022

Aug 09, 2022
BUY
$7.6 - $11.41 $181,024 - $271,774
23,819 New
23,819 $231,000

Others Institutions Holding KNSA

# of Institutions
8
Shares Held
1.95M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $687M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email